Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wasim K Bleibel

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Pharmacogenetics and Genomics|May 16, 2007
Gender-specific differences in expression in human lymphoblastoid cell linesWei Zhang, Wasim K Bleibel, Cheryl A Roe, et al.
Molecular Cancer Therapeutics|January 24, 2007
Effect of population and gender on chemotherapeutic agent-induced cytotoxicityRong Stephanie Huang, Emily O Kistner, Wasim K Bleibel, et al.
Biochemical Pharmacology|December 6, 2005
Role of GADD34 in modulation of cisplatin cytotoxicityMelissa L Fishel, Cara A Rabik, Wasim K Bleibel, et al.
Cancer Research|June 5, 2007
Mapping genes that contribute to daunorubicin-induced cytotoxicityShiwei Duan, Wasim K Bleibel, Rong Stephanie Huang, et al.
Pharmacogenetics and Genomics|May 23, 2008
Identification of genetic variants and gene expression relationships associated with pharmacogenes in humansRong Stephanie Huang, Shiwei Duan, Emily O Kistner, et al.
Pharmacogenomics|April 21, 2009
Expression and alternative splicing of folate pathway genes in HapMap lymphoblastoid cell linesShiwei Duan, R Stephanie Huang, Wei Zhang, et al.
Cancer Research|May 3, 2008
Genetic variants contributing to daunorubicin-induced cytotoxicityR Stephanie Huang, Shiwei Duan, Emily O Kistner, et al.
Human Genetics|December 18, 2008
Identification of genomic regions contributing to etoposide-induced cytotoxicityWasim K Bleibel, Shiwei Duan, R Stephanie Huang, et al.
Human Molecular Genetics|December 16, 2011
An eQTL-based method identifies CTTN and ZMAT3 as pemetrexed susceptibility markersYujia Wen, Eric R Gamazon, Wasim K Bleibel, et al.
RNA Biology|June 22, 2011
Population differences in microRNA expression and biological implicationsR Stephanie Huang, Eric R Gamazon, Dana Ziliak, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Pharmacogenetics and Genomics|May 16, 2007
Gender-specific differences in expression in human lymphoblastoid cell linesWei Zhang, Wasim K Bleibel, Cheryl A Roe, et al.
Molecular Cancer Therapeutics|January 24, 2007
Effect of population and gender on chemotherapeutic agent-induced cytotoxicityRong Stephanie Huang, Emily O Kistner, Wasim K Bleibel, et al.
Biochemical Pharmacology|December 6, 2005
Role of GADD34 in modulation of cisplatin cytotoxicityMelissa L Fishel, Cara A Rabik, Wasim K Bleibel, et al.
Cancer Research|June 5, 2007
Mapping genes that contribute to daunorubicin-induced cytotoxicityShiwei Duan, Wasim K Bleibel, Rong Stephanie Huang, et al.
Pharmacogenetics and Genomics|May 23, 2008
Identification of genetic variants and gene expression relationships associated with pharmacogenes in humansRong Stephanie Huang, Shiwei Duan, Emily O Kistner, et al.
Pharmacogenomics|April 21, 2009
Expression and alternative splicing of folate pathway genes in HapMap lymphoblastoid cell linesShiwei Duan, R Stephanie Huang, Wei Zhang, et al.
Cancer Research|May 3, 2008
Genetic variants contributing to daunorubicin-induced cytotoxicityR Stephanie Huang, Shiwei Duan, Emily O Kistner, et al.
Human Genetics|December 18, 2008
Identification of genomic regions contributing to etoposide-induced cytotoxicityWasim K Bleibel, Shiwei Duan, R Stephanie Huang, et al.
Human Molecular Genetics|December 16, 2011
An eQTL-based method identifies CTTN and ZMAT3 as pemetrexed susceptibility markersYujia Wen, Eric R Gamazon, Wasim K Bleibel, et al.
RNA Biology|June 22, 2011
Population differences in microRNA expression and biological implicationsR Stephanie Huang, Eric R Gamazon, Dana Ziliak, et al.
Pageof 2